82 FR 21256 - National Cancer Institute; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 82, Issue 86 (May 5, 2017)

Page Range		21256-21257
FR Document		2017-09052
Federal Register, Volume 82 Issue 86 (Friday, May 5, 2017)
[Federal Register Volume 82, Number 86 (Friday, May 5, 2017)]
[Notices]
[Pages 21256-21257]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-09052]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Initial Review 
Group; Subcommittee J--Career Development.
    Date: June 13-14, 2017.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, 
Bethesda, MD 20817.
    Contact Person: Tushar Deb, Ph.D., Scientific Review Officer, 
Resources & Training Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH 9609 Medical Center 
Drive, Room 7W624, Bethesda, MD 20892-9750, 240-276-6132, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI Omnibus R03.
    Date: June 15-16, 2017.
    Time: 8:00 a.m. to 12:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, Bethesda, MD 20852.
    Contact Person: Ombretta Salvucci, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W264, Bethesda, MD 20892-9750, 240-276-7286, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI Clinical and Translational R21 & Omnibus R03: SEP-9.
    Date: June 19-20, 2017.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, Bethesda, MD 20852.
    Contact Person: Jun Fang, Ph.D., Scientific Review Officer, 
Research Technology & Contract Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W246, Bethesda, MD 20892-9750, 240-276-5460, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI Research Specialist--R50.
    Date: June 22-23, 2017.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, Bethesda, MD 20852.
    Contact Person: Zhiqiang Zou, MD, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W242, Bethesda, MD 20892-9750, 240-276-6372, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI Clinical and Translational R21 & Omnibus R03: SEP 5.
    Date: June 23, 2017.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, Bethesda, MD 20852.
    Contact Person: Jennifer C Schiltz, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W264, Bethesda, MD 20892-9750, 240-276-5122, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI R03 & Clinical and Translational R21: SEP-8.
    Date: June 28-29, 2017.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, Bethesda, MD 20852.
    Contact Person: Eduardo E Chufan, Ph.D., Scientific Review 
Officer, Research Technology & Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W254, Bethesda, MD 20892-9750, 240-276-7975, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI R03 & Clinical and Translational R21: SEP-1.
    Date: June 28, 2017.
    Time: 11:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 2E030, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Ivan Ding, MD, Health Scientist Administrator, 
Program & Review Extramural Staff Training Office, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W534, Bethesda, MD 20892-9750, 240-276-6444, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Innovative Molecular and Cellular Analysis.
    Date: June 30, 2017.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, Bethesda, MD 20852.
    Contact Person: Yasuko Furumoto, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W634, Bethesda, MD 20892-9750, 240-276-5287, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; PDX Development and Trial Centers RFA CA-17-003 (U54) & RFA 
CA-17-004 (U24).
    Date: July 11-12, 2017.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, Bethesda, MD 20852.
    Contact Person: Timothy C. Meeker, MD, Scientific Review 
Officer, Resources and Training Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W606, Bethesda, MD 20892-9750, 240-276-6464, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Quantitative Imaging to Evaluate Response to Cancer Therapy.
    Date: July 12, 2017.
    Time: 11:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 2W030, Bethesda, MD 20892-9750 (Telephone 
Conference Call).
    Contact Person: Nadeem Khan, Ph.D., Scientific Review Officer, 
Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W260, Bethesda, MD 20892-9750, 240-276-6348, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction;

[[Page 21257]]

93.393, Cancer Cause and Prevention Research; 93.394, Cancer 
Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 
93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 
93.398, Cancer Research Manpower; 93.399, Cancer Control, National 
Institutes of Health, HHS)

    Dated: May 1, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-09052 Filed 5-4-17; 8:45 am]
 BILLING CODE 4140-01-P
21256 Federal Register / Vol. 82, No. 86 / Friday, May 5, 2017 / Notices

Nakayama at events@ Branch, Division of Extramural Activities, Name of Committee: National Cancer
nakamotogroup.com, or (240) 672–4011. National Cancer Institute, NIH, 9609 Medical Institute Special Emphasis Panel; NCI R03 &
Center Drive, Room 7W264, Bethesda, MD Clinical and Translational R21: SEP–1.
Authority: 42 U.S.C. 217a. The Secretary’s 20892–9750, 240–276–7286, salvucco@ Date: June 28, 2017.
Advisory Committee on National Health mail.nih.gov. Time: 11:00 a.m. to 4:00 p.m.
Promotion and Disease Prevention Objectives Agenda: To review and evaluate grant
for 2030 is governed by provisions of the Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI applications.
Federal Advisory Committee Act (FACA), Place: National Cancer Institute Shady
Public Law 92–463, as amended (5 U.S.C., Clinical and Translational R21 & Omnibus
R03: SEP–9. Grove, 9609 Medical Center Drive, Room
App.) which sets forth standards for the 2E030, Rockville, MD 20850 (Telephone
formation and use of federal advisory Date: June 19–20, 2017.
Time: 8:00 a.m. to 5:00 p.m. Conference Call).
committees. Contact Person: Ivan Ding, MD, Health
Agenda: To review and evaluate grant
Dated: May 1, 2017. applications. Scientist Administrator, Program & Review
Don Wright, Place: Bethesda North Marriott Hotel & Extramural Staff Training Office, Division of
Deputy Assistant Secretary for Health Conference Center, 5701 Marinelli Road, Extramural Activities, National Cancer
(Disease Prevention and Health Promotion). Bethesda, MD 20852. Institute, NIH, 9609 Medical Center Drive,
Contact Person: Jun Fang, Ph.D., Scientific Room 7W534, Bethesda, MD 20892–9750,
[FR Doc. 2017–09147 Filed 5–4–17; 8:45 am] 240–276–6444, dingi@mail.nih.gov.
Review Officer, Research Technology &
BILLING CODE 4150–32–P
Contract Review Branch, Division of Name of Committee: National Cancer
Extramural Activities, National Cancer Institute Special Emphasis Panel; Innovative
Institute, NIH, 9609 Medical Center Drive, Molecular and Cellular Analysis.
DEPARTMENT OF HEALTH AND Room 7W246, Bethesda, MD 20892–9750, Date: June 30, 2017.
HUMAN SERVICES 240–276–5460, jfang@mail.nih.gov. Time: 8:00 a.m. to 6:00 p.m.
Name of Committee: National Cancer Agenda: To review and evaluate grant
National Institutes of Health Institute Special Emphasis Panel; NCI applications.
Research Specialist—R50. Place: Bethesda North Marriott Hotel &
National Cancer Institute; Notice of Date: June 22–23, 2017. Conference Center, 5701 Marinelli Road,
Closed Meetings Time: 8:00 a.m. to 5:00 p.m. Bethesda, MD 20852.
Agenda: To review and evaluate grant Contact Person: Yasuko Furumoto, Ph.D.,
Pursuant to section 10(d) of the Scientific Review Officer, Research
applications.
Federal Advisory Committee Act, as Place: Bethesda North Marriott Hotel & Technology and Contract Review Branch,
amended (5 U.S.C. App.), notice is Conference Center, 5701 Marinelli Road, Division of Extramural Activities, National
hereby given of the following meetings. Bethesda, MD 20852. Cancer Institute, NIH, 9609 Medical Center
The meetings will be closed to the Contact Person: Zhiqiang Zou, MD, Ph.D., Drive, Room 7W634, Bethesda, MD 20892–
public in accordance with the Scientific Review Officer, Special Review 9750, 240–276–5287, yasuko.furumoto@
provisions set forth in sections Branch, Division of Extramural Activities, nih.gov.
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., National Cancer Institute, NIH, 9609 Medical Name of Committee: National Cancer
as amended. The grant applications and Center Drive, Room 7W242, Bethesda, MD Institute Special Emphasis Panel; PDX
the discussions could disclose 20892–9750, 240–276–6372, zouzhiq@ Development and Trial Centers RFA CA–17–
confidential trade secrets or commercial mail.nih.gov. 003 (U54) & RFA CA–17–004 (U24).
Name of Committee: National Cancer Date: July 11–12, 2017.
property such as patentable material, Time: 8:00 a.m. to 5:00 p.m.
and personal information concerning Institute Special Emphasis Panel; NCI
Clinical and Translational R21 & Omnibus Agenda: To review and evaluate grant
individuals associated with the grant R03: SEP 5. applications.
applications, the disclosure of which Date: June 23, 2017. Place: Bethesda North Marriott Hotel &
would constitute a clearly unwarranted Time: 8:00 a.m. to 5:00 p.m. Conference Center, 5701 Marinelli Road,
invasion of personal privacy. Agenda: To review and evaluate grant Bethesda, MD 20852.
applications. Contact Person: Timothy C. Meeker, MD,
Name of Committee: National Cancer
Place: Bethesda North Marriott Hotel & Scientific Review Officer, Resources and
Institute Initial Review Group; Subcommittee
Conference Center, 5701 Marinelli Road, Training Review Branch, Division of
J—Career Development.
Bethesda, MD 20852. Extramural Activities, National Cancer
Date: June 13–14, 2017.
Contact Person: Jennifer C Schiltz, Ph.D., Institute, NIH, 9609 Medical Center Drive,
Time: 8:00 a.m. to 5:00 p.m.
Scientific Review Officer, Special Review Room 7W606, Bethesda, MD 20892–9750,
Agenda: To review and evaluate grant
Branch, Division of Extramural Activities, 240–276–6464, meekert@mail.nih.gov.
applications.
Place: Bethesda Marriott Suites, 6711 National Cancer Institute, NIH, 9609 Medical Name of Committee: National Cancer
Democracy Boulevard, Bethesda, MD 20817. Center Drive, Room 7W264, Bethesda, MD Institute Special Emphasis Panel;
Contact Person: Tushar Deb, Ph.D., 20892–9750, 240–276–5122, jennifer.schiltz@ Quantitative Imaging to Evaluate Response to
Scientific Review Officer, Resources & nih.gov. Cancer Therapy.
Training Review Branch, Division of Name of Committee: National Cancer Date: July 12, 2017.
Extramural Activities, National Cancer Institute Special Emphasis Panel; NCI R03 & Time: 11:00 a.m. to 5:00 p.m.
Institute, NIH 9609 Medical Center Drive, Clinical and Translational R21: SEP–8. Agenda: To review and evaluate grant
Room 7W624, Bethesda, MD 20892–9750, Date: June 28–29, 2017. applications.
240–276–6132, tushar.deb@nih.gov. Time: 8:00 a.m. to 5:00 p.m. Place: National Cancer Institute Shady
Name of Committee: National Cancer Agenda: To review and evaluate grant Grove, 9609 Medical Center Drive, Room
Institute Special Emphasis Panel; NCI applications. 2W030, Bethesda, MD 20892–9750
Omnibus R03. Place: Bethesda North Marriott Hotel & (Telephone Conference Call).
SRADOVICH on DSK3GMQ082PROD with NOTICES

Date: June 15–16, 2017. Conference Center, 5701 Marinelli Road, Contact Person: Nadeem Khan, Ph.D.,
Time: 8:00 a.m. to 12:00 p.m. Bethesda, MD 20852. Scientific Review Officer, Research
Agenda: To review and evaluate grant Contact Person: Eduardo E Chufan, Ph.D., Technology and Contract Review Branch,
applications. Scientific Review Officer, Research Division of Extramural Activities, National
Place: Bethesda North Marriott Hotel & Technology & Contract Review Branch, Cancer Institute, NIH, 9609 Medical Center
Conference Center, 5701 Marinelli Road, Division of Extramural Activities, National Drive, Room 7W260, Bethesda, MD 20892–
Bethesda, MD 20852. Cancer Institute, NIH, 9609 Medical Center 9750, 240–276–6348, nadeem.khan@nih.gov.
Contact Person: Ombretta Salvucci, Ph.D., Drive, Room 7W254, Bethesda, MD 20892– (Catalogue of Federal Domestic Assistance
Scientific Review Officer, Special Review 9750, 240–276–7975, chufanee@mail.nih.gov. Program Nos. 93.392, Cancer Construction;

VerDate Sep<11>2014 17:43 May 04, 2017 Jkt 241001 PO 00000 Frm 00071 Fmt 4703 Sfmt 4703 E:\FR\FM\05MYN1.SGM 05MYN1
Federal Register / Vol. 82, No. 86 / Friday, May 5, 2017 / Notices 21257

93.393, Cancer Cause and Prevention Eunice Kennedy Shriver National Institute of Contact Person: Jeannette L. Johnson,
Research; 93.394, Cancer Detection and Child Health and Human Development, NIH, Ph.D., National Institutes on Aging, National
Diagnosis Research; 93.395, Cancer DHHS, 6710B Rockledge Drive, Rm. 2121D, Institutes of Health, 7201 Wisconsin Avenue,
Treatment Research; 93.396, Cancer Biology Bethesda, MD 20892–7501, 301–827–5435, Suite 2C212, Bethesda, MD 20892, 301–402–
Research; 93.397, Cancer Centers Support; minki.chatterji@nih.gov. 7705, johnsonj9@nia.nih.gov.
93.398, Cancer Research Manpower; 93.399, (Catalogue of Federal Domestic Assistance Name of Committee: National Institute on
Cancer Control, National Institutes of Health, Program Nos. 93.864, Population Research; Aging Special Emphasis Panel; DNA Repair
HHS) 93.865, Research for Mothers and Children; in Aging and AD Biomarkers.
Dated: May 1, 2017. 93.929, Center for Medical Rehabilitation Date: June 6, 2017.
Research; 93.209, Contraception and Time: 2:00 p.m. to 3:00 p.m.
Melanie J. Pantoja,
Infertility Loan Repayment Program, National Agenda: To review and evaluate grant
Program Analyst, Office of Federal Advisory Institutes of Health, HHS) applications.
Committee Policy. Place: National Institute on Aging,
[FR Doc. 2017–09052 Filed 5–4–17; 8:45 am] Dated: May 1, 2017. Gateway Building, Suite 2W200C, 7201
BILLING CODE 4140–01–P
Michelle Trout, Wisconsin Avenue, Bethesda, MD 20892
Program Analyst, Office of Federal Advisory (Telephone Conference Call).
Committee Policy. Contact Person: Greg Bissonette, Ph.D.,
DEPARTMENT OF HEALTH AND [FR Doc. 2017–09055 Filed 5–4–17; 8:45 am] Scientific Review Officer, National Institute
on Aging, National Institutes of Health,
HUMAN SERVICES BILLING CODE 4140–01–P
Gateway Building, Suite 2W200, 7201
Wisconsin Avenue, Bethesda, MD 20892,
National Institutes of Health 301–402–1622, bissonettegb@mail.nih.gov.
DEPARTMENT OF HEALTH AND Name of Committee: National Institute on
Eunice Kennedy Shriver National HUMAN SERVICES
Institute of Child Health & Human Aging Special Emphasis Panel; Gerontology
Research Training.
Development; Notice of Closed National Institutes of Health Date: June 6, 2017.
Meetings Time: 2:30 p.m. to 4:00 p.m.
National Institute On Aging; Notice of Agenda: To review and evaluate grant
Pursuant to section 10(d) of the Closed Meetings applications.
Federal Advisory Committee Act, as Place: National Institute on Aging,
amended (5 U.S.C. App.), notice is Pursuant to section 10(d) of the Gateway Building, Suite 2W200, 7201
hereby given of the following meetings. Federal Advisory Committee Act, as Wisconsin Avenue, Bethesda, MD 20892
The meetings will be closed to the amended (5 U.S.C. App.), notice is (Telephone Conference Call).
public in accordance with the hereby given of the following meetings. Contact Person: Jeannette L. Johnson,
provisions set forth in sections The meetings will be closed to the Ph.D., National Institutes on Aging, National
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., public in accordance with the Institutes of Health, 7201 Wisconsin Avenue,
as amended. The grant applications and provisions set forth in sections Suite 2C212, Bethesda, MD 20892, 301–402–
the discussions could disclose 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 7705, johnsonj9@nia.nih.gov.
confidential trade secrets or commercial as amended. The grant applications and (Catalogue of Federal Domestic Assistance
property such as patentable material, the discussions could disclose Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
and personal information concerning confidential trade secrets or commercial
individuals associated with the grant property such as patentable material, Dated: May 1, 2017.
applications, the disclosure of which and personal information concerning Melanie J. Pantoja,
would constitute a clearly unwarranted individuals associated with the grant Program Analyst, Office of Federal Advisory
invasion of personal privacy. applications, the disclosure of which Committee Policy.
Name of Committee: National Institute of would constitute a clearly unwarranted [FR Doc. 2017–09053 Filed 5–4–17; 8:45 am]
Child Health and Human Development Initial invasion of personal privacy. BILLING CODE 4140–01–P
Review Group; Population Sciences Name of Committee: National Institute on
Subcommittee. Aging Special Emphasis Panel; Longevity
Date: June 13, 2017. DEPARTMENT OF HEALTH AND
Consortium.
Time: 8:00 a.m. to 3:00 p.m. HUMAN SERVICES
Date: June 5, 2017.
Agenda: To review and evaluate grant
Time: 3:00 p.m. to 6:00 p.m.
applications. National Institutes of Health
Agenda: To review and evaluate grant
Place: Residence Inn Bethesda, 7335
applications.
Wisconsin Avenue, Bethesda, MD 20814. Eunice Kennedy Shriver National
Contact Person: Minki Chatterji, Scientific Place: National Institute on Aging,
Review Officer, Scientific Review Branch, Gateway Building, Suite 2W200, 7201 Institute of Child Health & Human
Eunice Kennedy Shriver National Institute of Wisconsin Avenue, Bethesda, MD 20892 Development; Notice of Closed
Child Health and Human Development, NIH, (Telephone Conference Call). Meetings
DHHS, 6710B Rockledge Drive, Rm. 2121D, Contact Person: Carmen Moten, Ph.D.,
Bethesda, MD 20892–7501, 301–827–5435, MPH., National Institute on Aging, Gateway Pursuant to section 10(d) of the
minki.chatterji@nih.gov. Building, 7201 Wisconsin Avenue, Suite Federal Advisory Committee Act, as
2C212, Bethesda, MD 20892, 301–402–7703, amended (5 U.S.C. App.), notice is
Name of Committee: National Institute of
cmoten@mail.nih.gov. hereby given of the following meetings.
Child Health and Human Development
Special Emphasis Panel; Archiving and Name of Committee: National Institute on The meetings will be closed to the
Documenting Child Health and Human Aging Special Emphasis Panel; Alzheimer’s public in accordance with the
SRADOVICH on DSK3GMQ082PROD with NOTICES

Development Data Sets (R03). Translational Research. provisions set forth in sections
Date: June 13, 2017. Date: June 6, 2017. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
Time: 3:00 p.m. to 5:00 p.m. Time: 1:00 p.m. to 2:30 p.m. as amended. The grant applications and
Agenda: To review and evaluate grant Agenda: To review and evaluate grant
applications.
the discussions could disclose
applications.
Place: Residence Inn Bethesda, 7335 Place: National Institute on Aging, confidential trade secrets or commercial
Wisconsin Avenue, Bethesda, MD 20814. Gateway Building, Suite 2W200, 7201 property such as patentable material,
Contact Person: Minki Chatterji, Scientific Wisconsin Avenue, Bethesda, MD 20892 and personal information concerning
Review Officer, Scientific Review Branch, (Telephone Conference Call). individuals associated with the grant

VerDate Sep<11>2014 17:43 May 04, 2017 Jkt 241001 PO 00000 Frm 00072 Fmt 4703 Sfmt 4703 E:\FR\FM\05MYN1.SGM 05MYN1
Document Created: 2018-11-08 08:40:06
Document Modified: 2018-11-08 08:40:06
Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		June 13-14, 2017.
FR Citation		82 FR 21256
82 FR 21256 - National Cancer Institute; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 82, Issue 86 (May 5, 2017)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
